UA110918C2 - Інгібітори протеїнфосфатази-1 та їх застосування - Google Patents
Інгібітори протеїнфосфатази-1 та їх застосуванняInfo
- Publication number
- UA110918C2 UA110918C2 UAA201013424A UAA201013424A UA110918C2 UA 110918 C2 UA110918 C2 UA 110918C2 UA A201013424 A UAA201013424 A UA A201013424A UA A201013424 A UAA201013424 A UA A201013424A UA 110918 C2 UA110918 C2 UA 110918C2
- Authority
- UA
- Ukraine
- Prior art keywords
- inhibitors
- protein phosphatase
- hiv
- infections
- replication
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D219/00—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
- C07D219/04—Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Було показано, що інгібітори протеїнфосфатази-1 уповільнюють реплікацію ВІЛ-1, Описуються інгібітори ПФ-1 і їх застосування в лікуванні або попередженні інфекцій ВІЛ-1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4556108P | 2008-04-16 | 2008-04-16 | |
PCT/US2009/040495 WO2009129224A1 (en) | 2008-04-16 | 2009-04-14 | Inhibitors of protein phosphatase-1 and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
UA110918C2 true UA110918C2 (uk) | 2016-03-10 |
Family
ID=41199444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201013424A UA110918C2 (uk) | 2008-04-16 | 2009-04-14 | Інгібітори протеїнфосфатази-1 та їх застосування |
Country Status (7)
Country | Link |
---|---|
US (1) | US8278326B2 (uk) |
EP (1) | EP2265117B1 (uk) |
AU (1) | AU2009236303B2 (uk) |
CA (1) | CA2721203C (uk) |
RU (1) | RU2527561C2 (uk) |
UA (1) | UA110918C2 (uk) |
WO (1) | WO2009129224A1 (uk) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2881967C (en) * | 2012-08-14 | 2021-02-23 | Howard University | Inhibitors of protein phosphatase-1 and uses thereof |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4559157A (en) | 1983-04-21 | 1985-12-17 | Creative Products Resource Associates, Ltd. | Cosmetic applicator useful for skin moisturizing |
LU84979A1 (fr) | 1983-08-30 | 1985-04-24 | Oreal | Composition cosmetique ou pharmaceutique sous forme aqueuse ou anhydre dont la phase grasse contient un polyether oligomere et polyethers oligomeres nouveaux |
JPS61106636A (ja) * | 1984-10-31 | 1986-05-24 | Toray Silicone Co Ltd | シリコ−ンゴムスポンジ組成物 |
US4820508A (en) | 1987-06-23 | 1989-04-11 | Neutrogena Corporation | Skin protective composition |
US4992478A (en) | 1988-04-04 | 1991-02-12 | Warner-Lambert Company | Antiinflammatory skin moisturizing composition and method of preparing same |
US5175172A (en) * | 1988-12-19 | 1992-12-29 | Francois Dietlin | Method of alleviating AIDS symptoms and compositions therefor |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
DE4444045C2 (de) * | 1994-12-10 | 1997-04-17 | Behringwerke Ag | Verfahren zur Inaktivierung von Viren mit Hilfe von Acridin oder Acridinderivaten |
US6593324B2 (en) * | 2000-03-01 | 2003-07-15 | Orion Corporation | Dervatives of quinoline as alpha-2 antagonists |
CN101146800A (zh) * | 2005-01-27 | 2008-03-19 | 生物工程大学精神物质实验室 | 用于治疗阿尔茨海默病的有机化合物,它们的用途和制备方法 |
RU2326115C2 (ru) * | 2005-11-21 | 2008-06-10 | Ефаг АО | Соли 1-алкиламино-1-дезоксиполиолов с 9-оксоакридин-10-уксусной кислотой, лекарственные препараты на их основе, применение, способы профилактики и лечения |
-
2009
- 2009-04-14 EP EP09732857.9A patent/EP2265117B1/en not_active Not-in-force
- 2009-04-14 AU AU2009236303A patent/AU2009236303B2/en not_active Ceased
- 2009-04-14 UA UAA201013424A patent/UA110918C2/uk unknown
- 2009-04-14 RU RU2010146147/04A patent/RU2527561C2/ru active
- 2009-04-14 WO PCT/US2009/040495 patent/WO2009129224A1/en active Application Filing
- 2009-04-14 CA CA2721203A patent/CA2721203C/en active Active
- 2009-04-15 US US12/424,243 patent/US8278326B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20090264463A1 (en) | 2009-10-22 |
AU2009236303B2 (en) | 2014-12-04 |
US8278326B2 (en) | 2012-10-02 |
EP2265117A1 (en) | 2010-12-29 |
CA2721203A1 (en) | 2009-10-22 |
CA2721203C (en) | 2016-11-01 |
EP2265117A4 (en) | 2012-03-21 |
RU2010146147A (ru) | 2012-05-27 |
EP2265117B1 (en) | 2017-06-07 |
WO2009129224A1 (en) | 2009-10-22 |
AU2009236303A1 (en) | 2009-10-22 |
RU2527561C2 (ru) | 2014-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1125144T1 (el) | Φαρμακευτικη συνθεση, μεθοδοι θεραπειας και χρηση αυτης | |
CY1120102T1 (el) | Συνθεσεις και μεθοδοι για μειωση τριγλυκεριδιων χωρις αυξηση επιπεδων ldl-c σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης | |
EA201001372A1 (ru) | Формы рифаксимина и их применение | |
CY1116509T1 (el) | Θεραπευτικος συνδυασμος που περιλαμβανει ντολουτεγκραβιρη, αβακαβιρη και λαμιβουδινη | |
CR20120266A (es) | Inmunoglobinas con dominio variable dual y usos de las mismas | |
EA201101117A1 (ru) | Ингибиторы дпп-4 для лечения диабета у детей | |
EA200901490A1 (ru) | Химические соединения | |
NO20082120L (no) | Behandling og forebyggelse av mikroangiopati | |
CL2008001234A1 (es) | Compuestos derivados de heterociclos nitrogenados, inhibidores de las proteinas de apoptosis; y uso en el tratamiento del cancer. | |
EA201391507A1 (ru) | АНТИТЕЛА ПРОТИВ c-Kit И ИХ ПРИМЕНЕНИЕ | |
EA201290131A1 (ru) | Производные пурина или деазапурина для применения при лечении вирусных инфекций и других заболеваний | |
EA201390803A1 (ru) | Ингибиторы бромодомена и их применение | |
RS53124B (en) | USE OF BETANECOL FOR THE TREATMENT OF XEROSOMOMY | |
BR112013010857A2 (pt) | imonoglubulinas de duplo domínio variável e usos das mesmas | |
MY160041A (en) | Compositions and methods for treating parasitic infections | |
EA201291031A1 (ru) | Способ лечения ожирения с применением антиоксидантных модуляторов воспаления | |
EA201390060A1 (ru) | Аннелированные пиримидины и триазины и их применение для лечения и/или профилактики сердечно-сосудистых заболеваний | |
CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
NO20092637L (no) | Fremgangsmater for behandling | |
EA201101521A1 (ru) | Способы лечения онкологических заболеваний, использующие эпиметаболические переключатели, многоаспектные внутриклеточные молекулы или факторы влияния | |
UA109650C2 (xx) | Біс-арилзв'язані арилтриазолони та їх застосування | |
NO20081354L (no) | Dobbelt variabelt domeneimmunoglobin samt fremgangsmater derav | |
RS53467B (en) | USE OF AMISULPRID FOR TREATMENT OF Nausea and Vomiting Caused by Chemotherapy | |
ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
DOP2011000354A (es) | Composiciones sublinguales de dexmedetomidina y metodos de uso de ellas |